3/23. Mometinib- (OiiJARA)- (Aug 2023)- to treat imtermediate on high risk myelofibrosis in adults with anemia
Drug Name:3/23. Mometinib- (OiiJARA)- (Aug 2023)- to treat imtermediate on high risk myelofibrosis in adults with anemia
List Of Brands:
3/23. Mometinib- (OiiJARA)- (Aug 2023)- to treat imtermediate on high risk myelofibrosis in adults with anemia
List Of Brands:
Free Mobile App
Designed By Quadwave
Home
About Us
FAQs
Feedback
Contact Us
Site Map
Copyright (c) inPharmation 2014
About Us
FAQs
Feedback
Contact Us
Site Map
Copyright (c) inPharmation 2014
Disclaimer: Every effort has been made to ensure that the information provided in
this Database is authentic and accurate. Commissions or omissions in the database,
if any, are purely inadvertent and the site owner shall not accept any liability
whatsoever for any adverse consequences of any nature arising to any individual
or third party, as a result of usage of this information.